What Happened?
Shares of medical technology company iRhythm Technologies (NASDAQ:IRTC) fell 2.8% in the afternoon session after a significant price target cut from an analyst overshadowed the company's strong quarterly earnings report.
Despite iRhythm beating second-quarter earnings estimates and raising its full-year revenue guidance, investor focus turned to a note from Truist. The firm lowered its price target on the stock to $18 from $160. While Truist maintained a Buy rating, the drastic reduction likely signaled concern to investors.
After the initial drop, the shares shed some of the losses and rose to $125.41, down 1.9% from the previous close.
The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy iRhythm? Access our full analysis report here, it’s free.
What Is The Market Telling Us
iRhythm’s shares are quite volatile and have had 19 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.
The previous big move we wrote about was 3 days ago when the stock gained 2% on the news that the company reported strong second-quarter financial results that surpassed expectations and raised its full-year guidance. The cardiac monitoring company posted revenue of $224.2 million, a 20.1% increase from the previous year, which topped Wall Street's estimates. Earnings per share came in at $0.58, also significantly beating consensus estimates of $0.00. Following the strong performance, iRhythm slightly lifted its revenue guidance for the full year to $885 million at the midpoint. Overall, it was a solid quarter for the company, highlighted by beats on both the top and bottom lines.
iRhythm is down 28.4% since the beginning of the year, and at $125.41 per share, it is trading 33.7% below its 52-week high of $189.25 from January 2026. Despite the year-to-date decline, investors who bought $1,000 worth of iRhythm’s shares 5 years ago would now be looking at an investment worth $2,616.
ALSO WORTH WATCHING: Nvidia’s Quiet Partner. Nvidia’s chips cost a hundred grand. The connectors that make them work cost even more. One company makes them all.
Every AI server needs specialized infrastructure the chip companies don’t make. High-speed cables. Power connectors. Thermal sensors. This 90-year-old company built a monopoly on it. The AI boom just started. This stock is still flying under the radar. Claim The Stock Ticker Here for FREE.